Renoprotective Effect of Sitagliptin ( Dipeptidyl Peptidase- 4 Inhibitor) aganist Cisplatin Induced Nephrotoxicity in Mice
Amany shalaby, Hala Abdel Malek
Journal of Pharmaceutical Research International · pp. 1116–1129 · Published 21 Apr 2014
10.9734/BJPR/2014/9297Abstract
Back Ground and Objectives: Despite the therapeutic benefits of cisplatin (CDDP), its use clinically is often limited due to dose-related nephrotoxicity. On the meanwhile, DPP 4 inhibitors could attenuate kidney injury, so in the present work, it was aimed to investigate the effect of one of DPP 4 inhibitors (sitagliptin) on cisplatin induced nephrotoxicity in mice. Materials and Methods: 48 male balb-c mice were equally divided into 4 groups, control, sitagliptin group, cisplatin group and cisplatin plus sitagliptin group. The mice were sacrificed at 72h after cisplatin injection. Blood urea nitrogen (BUN) & serum creatinine, renal tissue of antioxidant enzymes, lipid peroxidation, TNF-alpha (TNF-α) were measured as well as histopathological scoring of renal injury. Results: The results demonstrated that sitagliptin significantly ameliorated the nephrotoxic effect of cisplatin with increased activity of antioxidant enzymes, improved kidney function, renal histopathological scoring and decreased tissue level of TNF-α. Conclusions: It can be concluded that sitagliptin may play a protective effect against cisplatin induced acute nephrotoxicity via antioxidant and anti-inflammatory pathway.
References (44)
- 1 PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT [DOI]
- 2 Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction [DOI]
- 3 Atherosclerosis — An Inflammatory Disease [DOI]
- 4 Selenium: Biochemical Role as a Component of Glutathione Peroxidase [DOI]
- 5 Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance [DOI]
- 6 The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes [DOI]
- 7 Biology of Incretins: GLP-1 and GIP [DOI]
- 8 A modified spectrophotometric assay of superoxide dismutase.
- 9 Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides [DOI]
- 10 TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity [DOI]
- 11 GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice [DOI]
- 12 Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4 [DOI]
- 13 The severe cardiorenal syndrome: ‘Guyton revisited’ [DOI]
- 14 Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective Interventions [DOI]
- 15 Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury [DOI]
- 16 Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes [DOI]
- 17 Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats [DOI]
- 18 The effect of sodium nitrite on red cell GSH [DOI]
- 19 Manganese Superoxide Dismutase Attenuates Cisplatin-Induced Renal Injury [DOI]
- 20 Genetic Deletion or Pharmacological Inhibition of Dipeptidyl Peptidase-4 Improves Cardiovascular Outcomes After Myocardial Infarction in Mice [DOI]
- 21 Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death [DOI]
- 22 Naringenin attenuates cisplatin nephrotoxicity in rats [DOI]
- 23 Serum Interleukin-18 Levels Are Associated With Nephropathy and Atherosclerosis in Japanese Patients With Type 2 Diabetes [DOI]
- 24 Long-Term Treatment of Glucagon-Like Peptide-1 Analog Exendin-4 Ameliorates Diabetic Nephropathy through Improving Metabolic Anomalies in db/db Mice [DOI]
- 25 Dipeptidyl Peptidase IV Inhibitor Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats [DOI]
- 26 Differential roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells [DOI]
- 27 Diabetic Nephropathy Amelioration by a Low-Dose Sitagliptin in an Animal Model of Type 2 Diabetes (Zucker Diabetic Fatty Rat) [DOI]
- 28 A Novel Free Radical Scavenger, Edarabone, Protects Against Cisplatin-Induced Acute Renal Damage in Vitro and in Vivo [DOI]
- 29 DPP4 inhibition improves functional outcome after renal ischemia-reperfusion injury [DOI]
- 30 Effects of glucagon-like peptide-1 receptor agonists on renal function [DOI]
- 31 Long-term effects of chemotherapy in patients with testicular cancer. [DOI]
- 32 Protection from toxicant-mediated renal injury in the rat with anti-CD54 antibody [DOI]
- 33 Butein Ameliorates Renal Concentrating Ability in Cisplatin-Induced Acute Renal Failure in Rats [DOI]
- 34 Protection of Glucagon-Like Peptide-1 in Cisplatin-Induced Renal Injury Elucidates Gut-Kidney Connection [DOI]
- 35 Cisplatin induces renal expression of P-glycoprotein and canalicular multispecific organic anion transporter [DOI]
- 36 CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation [DOI]
- 37 A Novel Peptide Nanomedicine Against Acute Lung Injury: GLP-1 in Phospholipid Micelles [DOI]
- 38 Role of poly(ADP-ribose)polymerase in cisplatin-induced injury in LLC-PK1 cells [DOI]
- 39 Organic anion transporter 5 (Oat5) renal expression and urinary excretion in rats treated with cisplatin: a potential biomarker of cisplatin-induced nephrotoxicity [DOI]
- 40 Stimulation of hepatic glutathione formation by administration of L-2-oxothiazolidine-4-carboxylate, a 5-oxo-L-prolinase substrate. [DOI]
- 41 Intracellular cysteine and glutathione delivery systems. [DOI]
- 42 Primary Graft Dysfunction in Lung Transplantation: The Role of CD26/Dipeptidylpeptidase IV and Vasoactive Intestinal Peptide [DOI]
- 43 Glucagon-like peptide-1 attenuates tumour necrosis factor-α-mediated induction of plasmogen activator inhibitor-1 expression [DOI]
- 44 The Severe Cardiorenal Syndrome
Cited by 6
Ahmed M. Abd-Eldayem, Sohayla Mahmoud Makram, B. Messiha · Scientific Reports · 2024
Wei-Dong Jiang, Dacheng Wen, Zhaohua Cheng · Journal of biochemical and molecular toxicology · 2018
Rehab S. Abdelrahman · Naunyn-Schmiedeberg's Archives of Pharmacology · 2017
Abdelmonem G. Madboly, Eslam S. Metwally, Ghada A. Abd el-Fattah · 2019
Showing 4 of 6 known citations — external sources report more than can currently be individually listed.
Related research
- Trace Elements, Antioxidants, Uric Acid, C-Reactive Proteins and Estrogen Levels of Preeclamptic Pregnant Women in Owerri, Nigeria — shares topic coverage
- Effects of Selected Antioxidants on Atherosclerosis in Hyperlipidemic Wistar Rats — shares topic coverage
- Study of Antioxidants Vitamin E and Ascorbic Acid level in Pre-eclampsia and Normotensive Pregnant Women Attending the Antenatal Department of a Rural Hospital in Imo State South East Nigeria — shares topic coverage
- Antioxidant Protection Mechanisms in the Cardiovascular System — shares topic coverage
- Evaluation of Antioxidants, and Haematological Indices in Glaucoma Patients: A Case Study of Bayelsa State, Nigeria — shares topic coverage
Article metrics
Real usage data collected on this platform.
18
Page views
0
PDF downloads
1
Outbound clicks
6
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.